My cart
In the shopping cart is not goods, to choose and buy!
  • Product Name
  • Size
  • Quantity
  • Amount
    Selected items : 0 pieces Total : CHECK OUT()
    Catalog No: V3389
    CAS No. (CAS Registry Number): 4506-66-5
    Description: Y15 (also known as FAK inhibitor Y15 and FAK Inhibitor 14) is a novel, potent, specific and direct inhibitor of focal adhesion kinase (FAK) which blocks phosphorylation of Y397 with ...
    Catalog No: V3390
    CAS No. (CAS Registry Number): 18910-65-1 (free base); 94749-08-3 (Xinafoate)
    Description: Salmeterol (GR33343X) is a potent and long-acting β2-adrenergic receptor agonist with anti-inflammatory effects (Ki of 1.5 nM for WT β2AR, ), it is used in the treatment of...
    Catalog No: V3391
    CAS No. (CAS Registry Number): 1691249-44-1
    Description: (R)-Zanubrutinib is the R-enantiomer of Zanubrutinib (formerly known as BGB-3111) which is a novel, highly selective, second generation BTK inhibitor, currently under clinical invest...
    Catalog No: V3392
    CAS No. (CAS Registry Number): 1633350-06-7
    Description: (±)-Zanubrutinib is a racemic mixture of Zanubrutinib (formerly known as BGB-3111) which is a novel, highly selective, second generation BTK inhibitor, currently under clinical ...
    Catalog No: V3395
    CAS No. (CAS Registry Number): 841-67-8 [(S)-Thalidomide]; 50-35-1 (racemic); 2098488-36-7 (Azido-Thalidomide)
    Description: (S)-Thalidomide is the S-enantiomer of thalidomide (brand name Immunoprin) which is an immunomodulatory agent and the prototypic drug of the thalidomide class of drugs that are used mainl...
    Catalog No: V3396
    CAS No. (CAS Registry Number): 191732-72-6
    Description: Lenalidomide (Revlimid, CC-5013) is a derivative of thalidomide approved in the United States in 2005 for the treatment for myeloma and blood disorders called myelodysplastic sy...
    229页次3/39首页<12345678910...>尾页
    Products are for research use only;  We do not sell to patients
    Tel: 1-708-310-1919
    Fax: 1-708-557-7486
    Subscribe to our E-newsletter
    • Name*
    • *
    • E-mail*
    • *
    • instructions:
    • *
    Copyright 2020 InvivoChem LLC | All Rights Reserved